Stockreport

FibroBiologics Announces Payoff of Outstanding Debt

FibroBiologics, Inc.  (FBLG) 
PDF HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ pa [Read more]